Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide versus mesalazine suppositories in acute ulcerative proctitis
2012-003362-41Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide and Salcrozine in ulcerative proctitis (4 arms), sponsored by Dr. Falk Pharma GmbH. Primary endpoint: Time to resolution of clinical symptoms. Started Apr 2013; status: completed.
02
Drugs
budesonideSalcrozine
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on 2012-003362-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003362-41.